ALS RESEARCH GROUP DNA BANKING STUDY

点击翻译按钮获取中文摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Amyotrophic lateral sclerosis (ALS) and its related motor neuron disorders are progressive, devastating neurological diseases causing muscle weakness, breathing failure, and death, usually within 3 to 5 years. In most patients, the cause is unknown. The ALS Research Group DNA Banking study will look at genetic factors which may contribute to the development of ALS. To do so, researchers need blood samples and some basic health-related medical and family history information from both ALS patients and controls. Controls are people who do not have ALS. This study will safely and anonymously collect blood samples and health-related medical and family history for future ALS research. A group of 10 ALS care and research centers and clinics in the United States and Canada, including the University of Vermont, are working together to collect and submit blood samples for DNA banking to the National Institute of Neurological Disorders and Strokes (NINDS) Human Genetics Repository at Coriell Medical Research Institute in Camden, NJ . The results of this study will provide a collection of genetic material from the blood samples of ALS patients, and create an important national tool for future studies on the causes of ALS.